Lazard Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $373K | Buy |
19,125
+5,720
| +43% | +$113K | ﹤0.01% | 1499 |
|
|
2026
Q1 | $258K | Buy |
13,405
+2,630
| +24% | +$51.8K | ﹤0.01% | 1557 |
|
|
2025
Q4 | $204K | Sell |
10,775
-1,201
| -10% | -$22.3K | ﹤0.01% | 1649 |
|
|
2025
Q3 | $223K | Buy |
11,976
+4,504
| +60% | +$84.1K | ﹤0.01% | 1567 |
|
|
2025
Q2 | $137K | Sell |
7,472
-80,441
| -92% | -$1.43M | ﹤0.01% | 1793 |
|
|
2025
Q1 | $1.53M | Buy |
87,913
+16,066
| +22% | +$271K | ﹤0.01% | 1053 |
|
|
2024
Q4 | $1.24M | Buy |
71,847
+22,019
| +44% | +$402K | ﹤0.01% | 1057 |
|
|
2024
Q3 | $927K | Buy |
49,828
+26,148
| +110% | +$441K | ﹤0.01% | 1106 |
|
|
2024
Q2 | $364K | Buy |
+23,680
| New | +$338K | ﹤0.01% | 1332 |
|
|
2024
Q1 | – | Sell |
-8,475
| Closed | -$120K | – | 2341 |
|
|
2023
Q4 | $120K | Buy |
8,475
+5,698
| +205% | +$80.9K | ﹤0.01% | 1591 |
|
|
2023
Q3 | $38K | Buy |
+2,777
| New | +$35.5K | ﹤0.01% | 1928 |
|
|
2023
Q2 | – | Sell |
-2,427
| Closed | -$27K | – | 2510 |
|
|
2023
Q1 | $27K | Buy |
+2,427
| New | +$30K | ﹤0.01% | 1980 |
|
|
2022
Q4 | – | Sell |
-2,726
| Closed | -$35K | – | 2546 |
|
|
2022
Q3 | $35K | Hold |
2,726
| – | – | ﹤0.01% | 1934 |
|
|
2022
Q2 | $38K | Buy |
+2,726
| New | +$36.4K | ﹤0.01% | 1928 |
|
|
2021
Q4 | – | Sell |
-4,188
| Closed | -$61K | – | 2438 |
|
|
2021
Q3 | $61K | Buy |
4,188
+181
| +5% | +$3.06K | ﹤0.01% | 1592 |
|
|
2021
Q2 | $72K | Buy |
4,007
+2,139
| +115% | +$38.1K | ﹤0.01% | 1450 |
|
|
2021
Q1 | $32K | Buy |
1,868
+159
| +9% | +$2.8K | ﹤0.01% | 1630 |
|
|
2020
Q4 | $29K | Sell |
1,709
-1,087
| -39% | -$17.3K | ﹤0.01% | 1584 |
|
|
2020
Q3 | $38K | Buy |
2,796
+581
| +26% | +$8.53K | ﹤0.01% | 1272 |
|
|
2020
Q2 | $31K | Sell |
2,215
-443
| -17% | -$5.82K | ﹤0.01% | 1357 |
|
|
2020
Q1 | $29K | Buy |
2,658
+1,599
| +151% | +$29.5K | ﹤0.01% | 1366 |
|
|
2019
Q4 | $22K | Buy |
1,059
+418
| +65% | +$9.36K | ﹤0.01% | 1209 |
|
|
2019
Q3 | $14K | Buy |
+641
| New | +$13.7K | ﹤0.01% | 1191 |
|
|
2018
Q4 | – | Sell |
-7,501
| Closed | -$173K | – | 1077 |
|
|
2018
Q3 | $173K | Buy |
7,501
+968
| +15% | +$21.9K | ﹤0.01% | 886 |
|
|
2018
Q2 | $141K | Sell |
6,533
-383
| -6% | -$7.48K | ﹤0.01% | 876 |
|
|
2018
Q1 | $122K | Sell |
6,916
-3,722
| -35% | -$65.6K | ﹤0.01% | 886 |
|
|
2017
Q4 | $199K | Hold |
10,638
| – | – | ﹤0.01% | 874 |
|
|
2017
Q3 | $233K | Buy |
10,638
+10,358
| +3,699% | +$234K | ﹤0.01% | 765 |
|
|
2017
Q2 | $6K | Buy |
+280
| New | +$7.12K | ﹤0.01% | 951 |
|
|
2016
Q1 | – | Sell |
-1,383
| Closed | -$27K | – | 1103 |
|
|
2015
Q4 | $27K | Hold |
1,383
| – | – | ﹤0.01% | 957 |
|
|
2015
Q3 | $32K | Hold |
1,383
| – | – | ﹤0.01% | 938 |
|
|
2015
Q2 | $35K | Hold |
1,383
| – | – | ﹤0.01% | 987 |
|
|
2015
Q1 | $45K | Hold |
1,383
| – | – | ﹤0.01% | 976 |
|
|
2014
Q4 | $42K | Hold |
1,383
| – | – | ﹤0.01% | 1017 |
|
|
2014
Q3 | $33K | Hold |
1,383
| – | – | ﹤0.01% | 934 |
|
|
2014
Q2 | $39K | Hold |
1,383
| – | – | ﹤0.01% | 943 |
|
|
2014
Q1 | $38K | Hold |
1,383
| – | – | ﹤0.01% | 912 |
|
|
2013
Q4 | $36K | Hold |
1,383
| – | – | ﹤0.01% | 918 |
|
|
2013
Q3 | $31K | Buy |
1,383
+200
| +17% | +$4.93K | ﹤0.01% | 879 |
|
|
2013
Q2 | $30K | Buy |
+1,183
| New | +$34.1K | ﹤0.01% | 930 |
|
Other funds holding SBRA
CIM
Lazard Asset Management's SBRA Position: Q2 2026 in Review
Lazard Asset Management increased its Sabra Healthcare REIT (SBRA) stake by 43% in Q2 2026, buying an estimated $113K and bringing the position to 19,125 shares worth $373K. The position accounts for ﹤0.01% of the portfolio, ranked #1499.
Lazard Asset Management first reported a position in SBRA in Q2 2013 and has held it in 40 quarters since. The position peaked at $1.53M in Q1 2025. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.
- Lazard Asset Management held 19,125 shares of Sabra Healthcare REIT worth $373K as of Q2 2026.
- Lazard Asset Management bought 5,720 Sabra Healthcare REIT shares in Q2 2026, an estimated $113K.
- Sabra Healthcare REIT made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #1499 holding.
- Lazard Asset Management first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 40 quarters since.
- Lazard Asset Management's Sabra Healthcare REIT position peaked at $1.53M in Q1 2025.
- 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.
Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.